Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing Visual Function in Retinal Gene Therapy.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Spatial suppression of motion and motion segmentation in peripheral vision.

Journal of vision·2026
Same author

Discovery of Bis-Acyl Hydrazides as Potent and Bioavailable MTA-Cooperative PRMT5 Inhibitors: A Case Study of Leveraging the Deuterium Kinetic Isotope Effect.

Journal of medicinal chemistry·2025
Same author

Neural decoding of autobiographical mental image features with a general semantic model.

Nature communications·2025
Same author

Seeing a sunset: Exploring the joy of vision, in healthy eyes and ocular disease.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2025
Same author

A Common Representational Code for Event and Object Concepts in the Brain.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: May 13, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

How useful is population data for informing visual field progression rate estimation?

Andrew J Anderson1, Chris A Johnson

  • 1Department of Optometry and Vision Sciences, The University of Melbourne, Parkville, Australia. aaj@unimelb.edu.au

Investigative Ophthalmology & Visual Science
|March 7, 2013
PubMed
Summary

Bayesian estimators for visual field progression show modest improvements even when incorporating major risk factors like intraocular pressure treatment. Developing more sophisticated priors may yield limited gains in glaucoma progression rate estimation.

More Related Videos

Topographical Estimation of Visual Population Receptive Fields by fMRI
06:02

Topographical Estimation of Visual Population Receptive Fields by fMRI

Published on: February 3, 2015

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients
07:06

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients

Published on: March 29, 2022

Related Experiment Videos

Last Updated: May 13, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Topographical Estimation of Visual Population Receptive Fields by fMRI
06:02

Topographical Estimation of Visual Population Receptive Fields by fMRI

Published on: February 3, 2015

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients
07:06

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients

Published on: March 29, 2022

Area of Science:

  • Ophthalmology
  • Biostatistics
  • Medical Imaging

Background:

  • Bayesian estimators utilize population-level data (prior distributions) to refine individual rate estimates.
  • Glaucoma progression is influenced by various risk factors, including intraocular pressure (IOP) management.
  • Understanding the impact of risk factors on prior distributions is crucial for optimizing Bayesian methods.

Purpose of the Study:

  • To evaluate the benefit of incorporating IOP treatment status into Bayesian prior distributions for visual field progression.
  • To assess the potential gains from developing priors that account for other significant glaucoma risk factors.

Main Methods:

  • Prior distributions were created using published data from treated or untreated glaucoma patients.
  • Simulated visual field data (mean deviation values) were generated based on true progression rates.
  • Rates were estimated using linear regression and Bayesian methods, comparing matched-prior and unmatched-prior conditions.

Main Results:

  • For short visual field series, the matched-prior Bayesian approach showed a median error of 0.02 dB/y, compared to 0.20 dB/y for the unmatched-prior and 0.00 dB/y for linear regression.
  • Positive predictive values for identifying rapid progression (<-1 dB/y) were 0.46 (matched-prior), 0.42 (unmatched-prior), and 0.38 (regression).
  • Negative predictive values were high across all methods (0.93-0.95). Differences diminished with longer data series.

Conclusions:

  • The performance enhancement of Bayesian estimators for visual field progression is modest, even with priors that include major risk factors like IOP treatment.
  • The study suggests limited benefits from developing priors for other risk factors, indicating a plateau in performance gains.